Prelude Therapeutics, Inc. (PRLD)
3.38
+0.15
(+4.64%)
USD |
NASDAQ |
Oct 15, 11:50
Prelude Therapeutics Total Long Term Debt (Quarterly) : 14.87M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.87M |
| March 31, 2026 | 14.96M |
| December 31, 2025 | 15.04M |
| September 30, 2025 | 15.13M |
| June 30, 2025 | 15.21M |
| March 31, 2025 | 15.32M |
| December 31, 2024 | 15.53M |
| September 30, 2024 | 15.77M |
| June 30, 2024 | 15.97M |
| March 31, 2024 | 15.45M |
| December 31, 2023 | 15.41M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.39M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.312M |
| June 30, 2021 | 0.543M |
| March 31, 2021 | 0.84M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.067M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.258M |
| September 30, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Q32 Bio, Inc. | 4.561M |
| Intellia Therapeutics, Inc. | 50.07M |
| Twist Bioscience Corp. | 84.96M |
| Beam Therapeutics, Inc. | 232.15M |
| Revolution Medicines, Inc. | 1.174B |